NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/10/2024
Voltar para busca
Dado oficial do USPTO
ELIMSA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
18/10/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9
Data de depósito
18/02/2021
Data de registro
07/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/03/2023
Última transação
07/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
CA
Examinador
REID, CAILE MAUREEN
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
YYZ Pharmatech, Inc.
Representantes
Nicole K. McLaughlin DUANE MORRIS LLP
Classificação técnica
Classes Nice
Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic and test kitsdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Diagnostic and test kitsdrug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of proteinDNARNAantibodynanobodyaptamerpeptidebiopolymer; Diagnostic and test kitsdiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioninfectious diseasesoncology being cancersneurological diseasesimmunological diseasescardiovascular diseasesgenetic diseasesenvironmental diseasesdietary diseasespathogens; diagnostic reagents for medicinal use; medical diagnostic reagents; Kits for testing of body fluidsmedical diagnostic reagents and assays for testing body fluidstissues or cells for microorganisms; Kits for testing of body fluidsmedical diagnostic reagents and assays for testing of body fluids and tissue of cells for human healthcapture and detection reagents for environmental usehuman healthagriculturefood and nutrition; laboratory and scientific equipment for detectionquantification of analytesbiopolymers or germsdiagnosis of virusdisease and pathogensdiagnostic media for bacteriological culturesmedical diagnostic test media in the form of stripthreadsmulti-well platesmicrobeadsnanobeadsfor measuring pathological conditionphenotypic conditiongenotypic condition; and replacement parts and fittings therefor
Classe 9
Laboratory and scientific equipment for diagnostic testing and medical treatmenttest tubesmicroscope slidesincubatorslaboratory robotschromatography supports being chromatography apparatus for laboratory use; Laboratory and scientific equipment for diagnostic testing and medical treatmentdiagnostic apparatus for the detection of pathogens for laboratory or research use; Laboratory and scientific equipment for diagnostic testing and medical treatmentmedical diagnostic simulators for use as teaching aids for detecting pathogensDNA analysischromatography; electrophoresis laboratory apparatus and instruments for extracting biomolecules within enzyme-linked immunosorbent assaysimmunoblotspolymerase chain reactions (PCR)hybridizationbinding assaysnucleic acidsDNARNAproteinsantigensnot for medical purposes; analytical apparatus in the nature of an automated slide stainer for use in medical laboratories; and replacement parts and fittings therefor
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/07/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/06/2023
FIMP
FINAL DISPOSITION PROCESSED
12/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2023
GPNX
NOTIFICATION PROCESSED BY IB
21/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/12/2022
PUBO
PUBLISHED FOR OPPOSITION
20/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/11/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/11/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
27/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2022
ALIE
ASSIGNED TO LIE
14/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/11/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/11/2022
EXPI
EX PARTE APPEAL-INSTITUTED
02/11/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/11/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
02/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/05/2022
GNFR
FINAL REFUSAL E-MAILED
03/05/2022
CNFR
FINAL REFUSAL WRITTEN
03/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2022
DOCK
ASSIGNED TO EXAMINER
09/03/2022
RFNT
REFUSAL PROCESSED BY IB
30/10/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/10/2021
RFRR
REFUSAL PROCESSED BY MPU
05/10/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/09/2021
CNRT
NON-FINAL ACTION WRITTEN
20/09/2021
DOCK
ASSIGNED TO EXAMINER
14/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELIMSA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.